IMS Health Announces $250 Million Share Repurchase Authorization
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- L3Harris CEO steps down amid conduct review, shares drop
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Barclays Downgrades IMS Health Holdings (IMS) to Equalweight
December 17, 2015 7:31 AM ESTBarclays downgraded IMS Health Holdings (NYSE: IMS) from Overweight to Equalweight with a price target of $28.00 (from $33.00).
For an analyst ratings summary and ratings history on IMS Health Holdings click here. For more ratings news on IMS Health Holdings click here.
Shares of IMS Health Holdings closed at $25.71 yesterday.
... More
